[Results of 5-fluorocytosine therapy of aspergillosis and candidiasis].
D000293:Adolescent; D000328:Adult; D001228:Aspergillosis / Q000188:drug therapy*; D001232:Aspergillus fumigatus; D002177:Candidiasis / Q000188:drug therapy*; D002179:Candidiasis, Cutaneous / Q000188:drug therapy; D002648:Child; D003596:Cytosine / Q000031:analogs & derivatives*; D005260:Female; D005437:Flucytosine / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008172:Lung Diseases, Fungal / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D014552:Urinary Tract Infections / Q000188:drug therapy*
D003596:Cytosine; D005437:Flucytosine
Wyniki leczenia 5-fluorocytozyna chorych na aspergiloze i kandydiaze.